glp-1 multiple endocrine neoplasia Risk of pancreatic cancer associated with receptor agonist therapy Effect of combination treatment with

Jena, MD PhD Department of Health Care Policy, Harvard Medical School , Boston, MA Department of Medicine, Massachusetts General Hospital , Boston, MA National Bureau of Economic Research , Cambridge, MA, Nicholas Stucky, MD PhD Truveta, Inc , Bellevue, WA With the growing popularity of GLP-1 RAs, concerns have been raised that the expanded use may occur amongst patients with less clinical need

Taken altogether, these findings underscore the growing potential of dual/multi-agonist therapies to target the cardiometabolic phenotype closely linked to HFpEF

using digital tools to guide decisions about health)

The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity or 75 minutes of vigorous activity weekly, plus strength exercises on at least 2 days [14] Achieving and maintaining a healthy weight , as obesity is associated with altered metabolic hormone responses Prioritising sleep quality , as sleep deprivation affects multiple metabolic hormones Managing stress , which can impact appetite regulation and glucose control These approaches align with NICE guidance for preventing and managing type 2 diabetes (NG28) and obesity (CG189) and should be implemented as part of a holistic lifestyle approach

Return to Article Details GLP-1 receptor agonists in type 2 diabetes - NICE guidelines versus clinical practice